Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
MSCI Inc ha un obiettivo di prezzo di consenso pari a $610.86, stabilito in base alle ultime valutazioni degli analisti di 23. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, JP Morgan y UBS il julio 23, 2025, julio 21, 2025 y julio 8, 2025. Con un obiettivo di prezzo medio di $637.67 tra le Wells Fargo, JP Morgan y UBS, c'è un implicito 14.48% upside per MSCI Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/23/2025 | -4.31% | Wells Fargo | $578 → $533 | Maintains | Equal-Weight | |||
07/21/2025 | 22.08% | JP Morgan | $650 → $680 | Maintains | Overweight | |||
07/08/2025 | 25.67% | UBS | $655 → $700 | Maintains | Buy | |||
07/08/2025 | 3.77% | Wells Fargo | $530 → $578 | Maintains | Equal-Weight | |||
04/23/2025 | 13.28% | Evercore ISI Group | $673 → $631 | Maintains | Outperform | |||
04/16/2025 | 16.69% | JP Morgan | $680 → $650 | Maintains | Overweight | |||
04/16/2025 | 21.18% | RBC Capital | $675 → $675 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -4.85% | Wells Fargo | $532 → $530 | Maintains | Equal-Weight | |||
04/10/2025 | 5.02% | B of A Securities | → $585 | Initiates | → Neutral | |||
04/09/2025 | -4.49% | Wells Fargo | $623 → $532 | Maintains | Equal-Weight | |||
04/04/2025 | 16.69% | Barclays | $675 → $650 | Maintains | Overweight | |||
01/30/2025 | 21.18% | RBC Capital | $675 → $675 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 22.08% | JP Morgan | $700 → $680 | Maintains | Overweight | |||
01/30/2025 | 21.18% | Barclays | $700 → $675 | Maintains | Overweight | |||
01/21/2025 | 25.67% | JP Morgan | $680 → $700 | Maintains | Overweight | |||
12/18/2024 | 29.8% | Goldman Sachs | $617 → $723 | Upgrade | Neutral → Buy | |||
12/12/2024 | 24.77% | Morgan Stanley | $662 → $695 | Maintains | Overweight | |||
12/12/2024 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
10/30/2024 | 18.85% | Morgan Stanley | $640 → $662 | Maintains | Overweight | |||
10/30/2024 | 14.54% | RBC Capital | $638 → $638 | Reiterates | Outperform → Outperform | |||
10/30/2024 | 22.08% | UBS | $695 → $680 | Maintains | Buy | |||
10/11/2024 | 7.72% | Wells Fargo | $570 → $600 | Maintains | Equal-Weight | |||
10/09/2024 | 22.08% | Redburn Atlantic | → $680 | Upgrade | Neutral → Buy | |||
10/02/2024 | 23.87% | Evercore ISI Group | → $690 | Initiates | → Outperform | |||
09/13/2024 | 25.67% | Barclays | $650 → $700 | Maintains | Overweight | |||
08/12/2024 | 2.33% | Wells Fargo | → $570 | Initiates | → Equal-Weight | |||
07/26/2024 | 7.72% | Argus Research | $520 → $600 | Maintains | Buy | |||
07/24/2024 | 16.69% | Barclays | $600 → $650 | Maintains | Overweight | |||
07/24/2024 | 14.54% | RBC Capital | $638 → $638 | Reiterates | Outperform → Outperform | |||
07/24/2024 | 5.92% | Goldman Sachs | $526 → $590 | Maintains | Neutral | |||
07/24/2024 | 14.9% | Morgan Stanley | $615 → $640 | Maintains | Overweight | |||
07/09/2024 | 5.02% | UBS | $575 → $585 | Maintains | Buy | |||
06/25/2024 | 14.54% | RBC Capital | $638 → $638 | Reiterates | Outperform → Outperform | |||
05/13/2024 | -12.93% | Redburn Atlantic | → $485 | Upgrade | Sell → Neutral | |||
04/30/2024 | -5.75% | B of A Securities | $425 → $525 | Upgrade | Underperform → Neutral | |||
04/24/2024 | 3.23% | UBS | $700 → $575 | Maintains | Buy | |||
04/24/2024 | 7.72% | Barclays | $700 → $600 | Maintains | Overweight | |||
04/24/2024 | -5.57% | Goldman Sachs | $615 → $526 | Maintains | Neutral | |||
04/24/2024 | -23.7% | B of A Securities | $530 → $425 | Maintains | Underperform | |||
04/24/2024 | 10.41% | Morgan Stanley | $671 → $615 | Maintains | Overweight | |||
04/24/2024 | 2.15% | Deutsche Bank | $613 → $569 | Upgrade | Hold → Buy | |||
04/12/2024 | 14.54% | RBC Capital | $638 → $638 | Reiterates | Outperform → Outperform | |||
04/09/2024 | 16.33% | Oppenheimer | $659 → $648 | Maintains | Outperform | |||
03/26/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
02/01/2024 | 10.77% | Goldman Sachs | $544 → $617 | Maintains | Neutral | |||
01/31/2024 | 14.54% | RBC Capital | $588 → $638 | Maintains | Outperform | |||
01/31/2024 | 10.77% | Goldman Sachs | $544 → $617 | Maintains | Neutral | |||
01/31/2024 | 18.49% | Wells Fargo | $615 → $660 | Maintains | Overweight | |||
01/31/2024 | 25.67% | Barclays | $600 → $700 | Maintains | Overweight | |||
01/08/2024 | 7.9% | Oppenheimer | $572 → $601 | Maintains | Outperform | |||
01/05/2024 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
12/13/2023 | 7.72% | Morgan Stanley | $526 → $600 | Upgrade | Equal-Weight → Overweight | |||
11/01/2023 | 2.33% | RBC Capital | → $570 | Reiterates | Outperform → Outperform | |||
11/01/2023 | 7.72% | Barclays | $650 → $600 | Maintains | Overweight | |||
11/01/2023 | -5.57% | Morgan Stanley | $532 → $526 | Maintains | Equal-Weight | |||
11/01/2023 | -4.31% | Raymond James | $577 → $533 | Maintains | Outperform | |||
10/18/2023 | 7.72% | JP Morgan | $610 → $600 | Maintains | Overweight | |||
10/05/2023 | 10.05% | Oppenheimer | $620 → $613 | Maintains | Outperform | |||
09/14/2023 | -0.54% | Redburn Partners | → $554 | Downgrade | Buy → Neutral | |||
07/27/2023 | 4.48% | Goldman Sachs | $510 → $582 | Maintains | Neutral | |||
07/26/2023 | -4.49% | Morgan Stanley | $515 → $532 | Maintains | Equal-Weight | |||
07/26/2023 | -2.16% | RBC Capital | → $545 | Reiterates | Outperform → Outperform | |||
07/26/2023 | 14.9% | Wells Fargo | $570 → $640 | Maintains | Overweight | |||
07/26/2023 | 16.69% | Barclays | $600 → $650 | Maintains | Overweight | |||
07/26/2023 | 6.28% | Raymond James | $574 → $592 | Maintains | Outperform | |||
07/17/2023 | -19.21% | Exane BNP Paribas | → $450 | Downgrade | Neutral → Underperform | |||
07/14/2023 | 3.05% | Raymond James | $570 → $574 | Maintains | Outperform | |||
07/05/2023 | 4.66% | Oppenheimer | $595 → $583 | Maintains | Outperform | |||
06/15/2023 | -15.62% | B of A Securities | → $470 | Initiates | → Underperform | |||
05/09/2023 | 2.33% | Wells Fargo | → $570 | Initiates | → Overweight | |||
04/26/2023 | 7.72% | RBC Capital | → $600 | Reiterates | → Outperform | |||
04/26/2023 | 6.82% | Oppenheimer | $600 → $595 | Maintains | Outperform | |||
04/26/2023 | -7.54% | Morgan Stanley | $551 → $515 | Maintains | Equal-Weight | |||
04/26/2023 | -8.44% | Goldman Sachs | $567 → $510 | Maintains | Neutral | |||
04/26/2023 | 2.33% | Raymond James | $574 → $570 | Maintains | Outperform | |||
04/19/2023 | 5.92% | JP Morgan | $585 → $590 | Maintains | Overweight | |||
04/13/2023 | 3.05% | Raymond James | $549 → $574 | Maintains | Outperform | |||
04/04/2023 | 7.72% | Oppenheimer | $575 → $600 | Maintains | Outperform | |||
03/27/2023 | -1.08% | Morgan Stanley | $543 → $551 | Maintains | Equal-Weight | |||
02/02/2023 | 5.02% | JP Morgan | $580 → $585 | Maintains | Overweight | |||
02/01/2023 | -2.52% | Morgan Stanley | $518 → $543 | Maintains | Equal-Weight | |||
02/01/2023 | 7.72% | RBC Capital | $520 → $600 | Maintains | Outperform | |||
02/01/2023 | 3.23% | Oppenheimer | — | $510 → $575 | Maintains | Outperform | ||
02/01/2023 | -1.44% | Raymond James | $539 → $549 | Maintains | Outperform | |||
01/04/2023 | -7.01% | Morgan Stanley | $500 → $518 | Maintains | Equal-Weight | |||
12/13/2022 | 4.13% | JP Morgan | → $580 | Initiates | → Overweight | |||
12/02/2022 | 7.72% | Barclays | $470 → $600 | Maintains | Overweight | |||
10/26/2022 | -10.24% | Morgan Stanley | $505 → $500 | Maintains | Equal-Weight | |||
10/26/2022 | -7.72% | Raymond James | $499 → $514 | Maintains | Outperform | |||
10/20/2022 | -24.06% | Deutsche Bank | $513 → $423 | Maintains | Hold | |||
10/17/2022 | -10.42% | Raymond James | $510 → $499 | Maintains | Outperform | |||
08/16/2022 | -3.95% | Oppenheimer | $507 → $535 | Maintains | Outperform |
El último precio objetivo de MSCI (NYSE:MSCI) fue comunicado por Wells Fargo el julio 23, 2025. La firma de analistas fijó un precio objetivo para $533.00 que espera MSCI a fall dentro de 12 meses (un posible -4.31% downside). 25 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para MSCI (NYSE:MSCI) fue proporcionada por Wells Fargo, y MSCI mantuvo su equal-weight calificación.
La última revisión al alza de MSCI Inc se produjo en diciembre 18, 2024, cuando Goldman Sachs elevó su precio objetivo a $723. Goldman Sachs anteriormente tenía a neutral para MSCI Inc.
La última revisión a la baja de MSCI Inc se produjo en enero 5, 2024, cuando Raymond James cambió su precio objetivo de N/A a N/A para MSCI Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de MSCI, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de MSCI se registró el julio 23, 2025, por lo que la próxima calificación estará disponible en torno al julio 23, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de MSCI (MSCI) fue un mantuvo con un precio objetivo de $578.00 a $533.00. El precio actual al que cotiza MSCI (MSCI) es de $557.02, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.